These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34151162)

  • 1.
    Okuda S; Wajima T; Yamada T; Nakaminami H; Ikoshi H; Noguchi N
    Access Microbiol; 2021 Mar; 3(3):000208. PubMed ID: 34151162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus acidophilus attenuates toxin production by Vibrio cholerae and shigella dysenteriae following intestinal epithelial cells infection.
    Alamdary SZ; Bakhshi B
    Microb Pathog; 2020 Dec; 149():104543. PubMed ID: 33010360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin.
    O'Brien AD; Chen ME; Holmes RK; Kaper J; Levine MM
    Lancet; 1984 Jan; 1(8368):77-8. PubMed ID: 6140426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae.
    Okuda J; Kurazono H; Takeda Y
    Microb Pathog; 1995 Mar; 18(3):167-72. PubMed ID: 7565011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.
    FRETER R
    J Exp Med; 1956 Sep; 104(3):411-8. PubMed ID: 13357693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibilities of enteric bacterial pathogens isolated in Kathmandu, Nepal, during 2002-2004.
    Kansakar P; Baral P; Malla S; Ghimire GR
    J Infect Dev Ctries; 2011 Mar; 5(3):163-8. PubMed ID: 21444984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of portulaca oleracea L. extracts against porcine epidemic diarrhea virus by partial suppression on myd88/NF-κb activation in vitro.
    Liu Y; Zhao L; Xie Y; Chen Z; Yang S; Yin B; Li G; Guo H; Lin S; Wu J
    Microb Pathog; 2021 May; 154():104832. PubMed ID: 33781871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Component Composition and Antimicrobial Activity of CO
    Tleubayeva MI; Datkhayev UM; Alimzhanova M; Ishmuratova MY; Korotetskaya NV; Abdullabekova RM; Flisyuk EV; Gemejiyeva NG
    ScientificWorldJournal; 2021; 2021():5434525. PubMed ID: 33551685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.
    O'Ryan M; Vidal R; del Canto F; Salazar JC; Montero D
    Hum Vaccin Immunother; 2015; 11(3):584-600. PubMed ID: 25715048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed infections of Vibrio cholerae O1 Ogawa EL Tor with Shigella dysenteriae.
    Gharibi O; Mirzaei K; Karimi A; Darabi H
    Pak J Biol Sci; 2010 Nov; 13(22):1110-2. PubMed ID: 21313886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hepato-protective Effects of Portulaca oleracea L. extract: Review.
    Farkhondeh T; Samarghandian S; Azimi-Nezhad M; Hozeifi S
    Curr Drug Discov Technol; 2019; 16(2):122-126. PubMed ID: 29600768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory activities of Typhonium trilobatum (L.) Schott on virulence potential of multi-drug resistant toxigenic Vibrio cholerae.
    Saha P; Banerjee A; Banerjee G; Bag PK
    Microb Pathog; 2022 Apr; 165():105485. PubMed ID: 35318072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation and Identification of Four New Compounds with Antibacterial Activity from Portulaca oleracea L.
    Lei X; Li J; Liu B; Zhang N; Liu H
    Molecules; 2015 Sep; 20(9):16375-87. PubMed ID: 26378504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo bactericidal activity of Vitex negundo leaf extract against diverse multidrug resistant enteric bacterial pathogens.
    Kamruzzaman M; Bari SM; Faruque SM
    Asian Pac J Trop Med; 2013 May; 6(5):352-9. PubMed ID: 23608373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic effects of Portulaca oleracea L. in hepatogastric disorders.
    Farkhondeh T; Samarghandian S
    Gastroenterol Hepatol; 2019 Feb; 42(2):127-132. PubMed ID: 30327154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy interrupting effects of some bacterial toxins.
    Sechser T; Vanĕcek J; Rasková H; Jiricka Z; Matĕjovská D; Matĕjovská V
    Physiol Bohemoslov; 1976; 25(2):155-8. PubMed ID: 178014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.
    Wu T; Grassel C; Levine MM; Barry EM
    Infect Immun; 2011 Dec; 79(12):4912-22. PubMed ID: 21969003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive Survival of Escherichia coli, Vibrio cholerae, Salmonella typhimurium and Shigella dysenteriae in Riverbed Sediments.
    Abia AL; Ubomba-Jaswa E; Momba MN
    Microb Ecol; 2016 Nov; 72(4):881-889. PubMed ID: 27193001
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Fu Q; Zhou S; Yu M; Lu Y; He G; Huang X; Huang Y
    Front Microbiol; 2022; 13():841397. PubMed ID: 35308364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.